Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone + Niclosamide in CRPC
NCT02807805Phase 2Active, not recruiting
- Start
- Oct 2016
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niclosamide in castration-resistant prostate cancer (CRPC). Started Oct 2016; status: active, not recruiting.
02
Drugs
niclosamide
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT02807805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807805.